Metraipolis › archive › dc_47698b62e7bf

Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways — Europe PMC PMID:42370183

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42370183
DOI
10.7150/thno.127500
License (as archived)
solo-consultazione
Archived
2026-10-19T09:14:02.723Z
SHA-256 of the archived text
adbef64ccf403c3998d6c7fcbd2ac8d18df8ba2d7164631077c98e9e669f39d6
Stable URL of this page
https://metraipolis.com/documento/dc_47698b62e7bf

How to cite

Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways — Europe PMC PMID:42370183 — Europe PMC (en), https://europepmc.org/article/MED/42370183 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_47698b62e7bf (Metraipolis archive dc_47698b62e7bf, sha256 adbef64ccf403c3998d6c7fcbd2ac8d18df8ba2d7164631077c98e9e669f39d6)
BibTeX
@misc{dc47698b62e7bf,
  title = {Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways — Europe PMC PMID:42370183},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42370183},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_47698b62e7bf; sha256 adbef64ccf403c3998d6c7fcbd2ac8d18df8ba2d7164631077c98e9e669f39d6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42370183. Agents can read the archived copy with the MCP tool read_document.